INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 216 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $980,000 | -60.0% | 196,351 | -42.7% | 0.18% | -25.8% |
| Q3 2021 | $2,452,000 | +123.7% | 342,414 | +189.5% | 0.24% | +53.2% |
| Q2 2021 | $1,096,000 | -63.4% | 118,270 | -65.1% | 0.15% | -77.6% |
| Q1 2021 | $2,997,000 | 0.0% | 338,601 | 0.0% | 0.69% | +1.0% |
| Q4 2020 | $2,997,000 | +1186.3% | 338,601 | +1587.8% | 0.68% | +1264.0% |
| Q3 2020 | $233,000 | – | 20,062 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 100,274 | $82 | 0.01% |